Endress+Hauser Group Mourns Company Founder

Fuel for thought

Endress+Hauser Group Mourns Company Founder

26 Jan, 2009

Published over 17 years ago. See the latest and most current information on Fuel for thought.

Dr Georg H Endress has passed away at the age of 84. Family and foundation guarantee the continuance of his life’s work.
The Endress+Hauser Group is mourning their founder Dr Georg H Endress. The entrepreneur died on 14 December 2008 after a brief, grave illness a few weeks before his 85th birthday, surrounded by his family in Arlesheim, Switzerland. Employees of the family-owned Group around the world reacted with sorrow at the news. Their deepest sympathies are conveyed to his wife Alice Endress-Vogt and the couple’s large family.
As an entrepreneur and patron, Georg H Endress leaves a thriving work, distinguished by its farsightedness and courage, transcending borders in many respects. The core of Georg H Endress life’s work is the establishment of the Endress+Hauser Group. From small beginnings, the Group developed into an international company for industrial measurement
and automation engineering with over 8,300 employees worldwide. “I wanted to prove to myself, my family and the world that I could carry an idea through to success,” Georg H Endress once stated in reply to the question of why he became an entrepreneur. And with his unique sense of humor, he added: “When we were expecting our third child, my wife challenged me to do something so I became an entrepreneur.”

Latest News

PIN 27.3 June/July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Labmate Online
SERS bismuth nanoparticles sensor can spot lead ions in water at high sensitivity
Explore more Arrow
Envirotech Online
FM approval strengthens intelligent fixed gas detection for refineries and petrochemical plants
Explore more Arrow
Pollution Solutions Online
Slurry grant a fossil fuel failure?
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow